# Silvio Danese

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/silvio-danese/

## Facts

| Field | Value |
| --- | --- |
| Citations | 90,647 |
| Field | Inflammatory Bowel Disease |
| h-index | 141 |
| i10-index | 917 |
| Last Known Institution | Vita-Salute San Raffaele University |
| OpenAlex ID | https://openalex.org/A5047563454 |
| ORCID iD | 0000-0001-7341-1351 |
| Works | 2,311 |

## Researcher papers

Showing 12 of 26.

- [Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis](https://scholariq.org/papers/vedolizumab-as-induction-and-maintenance-therapy-for-ulcerative-colitis/)
- [STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD](https://scholariq.org/papers/stride-ii-an-update-on-the-selecting-therapeutic-targets-in-inflammatory-bowel/)
- [Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target](https://scholariq.org/papers/selecting-therapeutic-targets-in-inflammatory-bowel-disease-stride-determining/)
- [Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis](https://scholariq.org/papers/tofacitinib-as-induction-and-maintenance-therapy-for-ulcerative-colitis/)
- [Ulcerative colitis](https://scholariq.org/papers/ulcerative-colitis-2/)
- [The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management](https://scholariq.org/papers/the-second-european-evidence-based-consensus-on-the-diagnosis-and-management-of-2/)
- [Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis](https://scholariq.org/papers/ustekinumab-as-induction-and-maintenance-therapy-for-ulcerative-colitis/)
- [Ulcerative Colitis](https://scholariq.org/papers/ulcerative-colitis-3/)
- [Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial](https://scholariq.org/papers/expanded-allogeneic-adipose-derived-mesenchymal-stem-cells-cx601-for-complex/)
- [Epithelial NEMO links innate immunity to chronic intestinal inflammation](https://scholariq.org/papers/epithelial-nemo-links-innate-immunity-to-chronic-intestinal-inflammation/)
- [Crohn’s disease](https://scholariq.org/papers/crohn-s-disease/)
- [Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines](https://scholariq.org/papers/imaging-techniques-for-assessment-of-inflammatory-bowel-disease-joint-ecco-and/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)

## Researcher university

- [Vita-Salute San Raffaele University](https://scholariq.org/institutions/vita-salute-san-raffaele-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.